Two Sigma Advisers
PFE icon

Two Sigma Advisers’s Pfizer PFE Stock Holding History

Two Sigma Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-104,135
Closed -$3.08M – 2273
2014
Q4 		$3.08M Sell
104,135
-79,261
-43% -$2.27M 0.02% 653
2014
Q3 		$5.14M Sell
183,396
-32,779
-15% -$920K 0.04% 494
2014
Q2 		$6.09M Sell
216,175
-17,813
-8% -$508K 0.05% 415
2014
Q1 		$7.13M Sell
233,988
-131,750
-36% -$3.93M 0.06% 327
2013
Q4 		$10.6M Sell
365,738
-433,510
-54% -$12.6M 0.1% 212
2013
Q3 		$21.8M Buy
799,248
+754,980
+1,705% +$20.5M 0.26% 80
2013
Q2 		$1.18M Buy
+44,268
New +$1.22M 0.02% 775

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Two Sigma Advisers's PFE Position: Q1 2026 in Review

Two Sigma Advisers sold out of Pfizer (PFE) in Q1 2026, closing a stake of 14,800 shares — an estimated $369K sold.

Two Sigma Advisers first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $497M in Q2 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Two Sigma Advisers reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 14,800 Pfizer shares in Q1 2026, an estimated $369K.
  • Two Sigma Advisers first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
  • Two Sigma Advisers's Pfizer position peaked at $497M in Q2 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.